http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2013200398-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0eb3e981dd7eddec8673b4e19b35708b |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2013-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0eacd31bc73310c0e9116659a81d77a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc02a35e01186635fb0fae20a89fa95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8faffda23e5ce3016c8f4a3d874e2d21 |
| publicationDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2013200398-A1 |
| titleOfInvention | Soluble Urokinase Plasminogen Activator Receptor (suPAR) as Marker for Diseases |
| abstract | The invention concerns a marker for low-grade inflammation and metabolic syndrome (MS) and MS-related diseases and/or low-grade inflammation-related diseases such as cardiovascular disease, ischemic heart disease and type 2 diabetes. More particularly it concerns the measurement of the concentration of soluble urokinase plasminogen activator receptor (suPAR) in human biological fluids (sputum, cystic fluid, ascites, serum, plasma, urine) as a tool of diagnosing and/or prognosticating low-grade inflammation, metabolic syndromes and the risk of development of related diseases such as cancer, cardiovascular disease, ischemic heart disease and type 2 diabetes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017075268-A1 |
| priorityDate | 2006-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 452.